Home・Список акций・Zoetis Inc

Zoetis Inc

Закрыт

СекторЗдравоохранение

75.98 -1.43

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

76.83

Макс.

79.78

Ключевые показатели
By Trading Economics
Доход	-2M 601M
Продажи	-125M 2.3B
P/E Средняя по отрасли	12.61 64.641
Прибыль на акцию	1.53
Дивидендная доходность	2.69
Рентабельность продаж	26.569
Сотрудники	14,500
EBITDA	-8M 939M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+28.58% upside

Дивиденды
By Acuity
Дивидендная доходность Средняя по отрасли	2.69% 2.31%
Следующий отчет о доходах	6 авг. 2026 г.
Дата следующей выплаты дивидендов	1 сент. 2026 г.
Следующая эксдивидендная дата	30 окт. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-16B 32B
Предыдущая цена открытия	77.41
Предыдущая цена закрытия	75.98

Новостные настроения

By Acuity

43%

57%

135 / 340 Рейтинг в Healthcare

Zoetis Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

3 авг. 2026 г., 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1 авг. 2026 г., 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31 июл. 2026 г., 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30 июл. 2026 г., 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29 июл. 2026 г., 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28 июл. 2026 г., 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27 июл. 2026 г., 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25 июл. 2026 г., 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24 июл. 2026 г., 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23 июл. 2026 г., 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22 июл. 2026 г., 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21 июл. 2026 г., 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20 июл. 2026 г., 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Сравнение c конкурентами

Изменение цены

Zoetis Inc Прогноз

Целевая цена

By TipRanks

28.58% рост

Прогноз на 12 месяцев

Средняя 99.38 USD 28.58%

Максимум 130 USD

Минимум 85 USD

Основано на мнении 12 аналитиков Wall Street, спрогнозировавших целевые цены для Zoetis Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

12 ratings

Покупка

Удержание

Продажа

Основано на мнении 12 аналитиков, присваивавших рейтинги акциям Zoetis Inc – Данные за последние 3 месяца.

Настроения

By Acuity

135 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.